Jul 27, 2013 - 10:04 am
I know many of our sisters are on PARP trials . This is fantastic news on the phase 2 PARP BMN 673 for breast cancer. Yes, breast, but read on. I was told that the OVCA results were expected to be released shortly and are as good or better. It seems the BMN 673 had a 50% response rate with numerous "complete" responses. The results were so awesome that they are going straight to phase 3 -- like NOW -- for breast and ovarian, and once phase 3 is out, FDA is expected to fast track it. Could be available by prescription by January!
Here is the link: http://www.benzinga.com/news/13/07/3784909/biomarin-provides-bmn-673-progra m-uupdated
I found this info on another site and wanted to pass along to everyone.